Dr. Shahzad Raza, MD
Position:
Director of Malignant Hematology Program/Saint Luke’s Cancer Institute
Research Focus:
Dr. Shahzad Raza's research interests include incorporation of monoclonal immunotherapy in combination of IMiDs and proteasome inhibitor in the management of multiple myeloma and formulate personalized treatment care plan for these patients. We are also studying proteomic characteristics in multiple myeloma and its use as signature molecule for potential new therapeutic targets.
years treating myeloma: 6+
Number of Myeloma Patients Treated Annually: 150
Details & contact info
4321 Washington Ste 4000
Kansas City, MO, United States, 64111
Phone: (816) 932-3300
Send a message to Dr. Shahzad Raza, MD
. 
. 
